APH — Alliance Pharma Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Alliance Pharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	8.03	7.32	0.936	-33.1	-10.7
Depreciation
Amortisation
Non-Cash Items	22	16.5	37.2	73.9	4.9
Unusual Items
Other Non-Cash Items
Changes in Working Capital	2.61	-1.42	-18.7	-19.7	-1.66
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	41.6	38.7	21	31.4	38.7
Capital Expenditures	-4.61	-5.53	-0.607	-0.696	-0.841
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-81.3	0.933	-16.4	-0.222	2.9
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-85.9	-4.6	-17	-0.918	2.06
Financing Cash Flow Items	-3.23	-2.96	-4.8	-10.8	-8.82
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	55.7	-34.3	-0.876	-39.2	-30.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	11.1	0.163	2.65	-9.28	9.92